RESUMEN
AIMS: To determine the burden of disease in a unique sample of patients with uveitis from a rural South African setting. METHODS: Data in this cross-sectional study were collected from patients presenting with uveitis (n=103) at the ophthalmology outpatient department of three hospitals in rural South Africa. Demographic and clinical data were collected, and laboratory analysis of aqueous humour, serological evaluation and routine diagnostics for tuberculosis (TB) were performed. RESULTS: Sixty-six (64%) participants were HIV infected. Uveitis was predominantly of infectious origin (72%) followed by idiopathic (16%) and autoimmune (12%). Infectious uveitis was attributed to herpes virus (51%), Mycobacterium tuberculosis (24%) and Treponema pallidum (7%) infection. HIV-infected individuals were more likely to have infectious aetiology of uveitis compared with HIV-uninfected individuals (83% vs 51%; p=0.001). CONCLUSIONS: Microbial aetiology of uveitis is common in areas where HIV and TB are endemic. In these settings, a high index of suspicion for infectious origin of uveitis is warranted.
Asunto(s)
Infecciones Bacterianas del Ojo/epidemiología , Infecciones por VIH/epidemiología , VIH , Población Rural , Tuberculosis/epidemiología , Uveítis/epidemiología , Adulto , Anciano , Anciano de 80 o más Años , Estudios Transversales , Infecciones Virales del Ojo , Femenino , Humanos , Masculino , Persona de Mediana Edad , Prevalencia , Estudios Retrospectivos , Sudáfrica/epidemiología , Uveítis/microbiología , Uveítis/virología , Adulto JovenRESUMEN
OBJECTIVES: To describe the spectrum of ocular complications of herpes zoster ophthalmicus (HZO) in rural South Africa. METHODS: Patients presenting with visual complaints and active or healed HZO at the ophthalmology outpatient department of three hospitals in rural South Africa were included in this study. Demographic and clinical data were collected, and HIV status was determined for all participants. RESULTS: Forty-eight patients were included, and 81% were HIV infected. Poor vision was reported by 94% of patients, painful eye by 79% and photophobia by 63%. A diverse spectrum of ocular complications was observed with corneal inflammation and opacification in 77% followed by anterior uveitis in 65%. The majority (65%) presented with late-stage ocular complications associated with irreversible loss of vision whereas early-stage complications, such as punctate epithelial keratitis and anterior uveitis, were less common. Blindness of the affected eye was observed in 68% of patients with late-stage complications. There was a considerable delay between onset of symptoms and first presentation to the ophthalmology outpatient department (median time 35 days; range 1-2500 days), and longer delay was associated with late-stage ocular complications (P = 0.02). CONCLUSIONS: HZO patients present with relatively late-stage ocular complications, and blindness among these patients is common. The delayed presentation to the ophthalmology outpatient department of hospitals in our rural setting is of concern, and efforts to improve ocular outcomes of HZO are urgently needed.
Asunto(s)
Herpes Zóster Oftálmico/complicaciones , Adolescente , Adulto , Anciano , Ceguera/etiología , Ceguera/virología , Diagnóstico Tardío/efectos adversos , Dolor Ocular/etiología , Femenino , Infecciones por VIH/complicaciones , Herpesvirus Humano 3 , Humanos , Masculino , Persona de Mediana Edad , Fotofobia/etiología , Población Rural , Sudáfrica , Adulto JovenRESUMEN
Infectious uveitis is a significant cause of blindness in South Africa, especially among HIV-infected individuals. The visual outcome of uveitis depends on early clinical and laboratory diagnosis to guide therapeutic intervention. Analyses of aqueous humor, obtained by anterior chamber paracentesis, directs the differential diagnosis in infectious uveitis. However, although safe and potentially cost-effective, diagnostic anterior chamber paracentesis is not common practice in ophthalmic care across Africa. We seek to draw attention to this important procedure that could improve the diagnosis and prognosis of infectious uveitis.
Asunto(s)
Cámara Anterior , Paracentesis , Uveítis/diagnóstico , Uveítis/terapia , Cámara Anterior/microbiología , Comorbilidad , Infecciones por VIH/epidemiología , Humanos , Sudáfrica , Uveítis/epidemiología , Uveítis/microbiologíaRESUMEN
Mycobacterium tuberculosis infection is an important cause of sight-threatening chorioretinitis in HIV-infected individuals living in M. tuberculosis endemic areas. We present a case of tuberculous chorioretinitis in a HIV-infected man after recent initiation of antiretroviral therapy in rural South Africa, who had nearly complete resolution of clinical signs and symptoms after standard tuberculosis treatment. His presentation was most likely associated with immune reconstitution inflammatory syndrome.
Asunto(s)
Infecciones Oportunistas Relacionadas con el SIDA/tratamiento farmacológico , Terapia Antirretroviral Altamente Activa , Antituberculosos/uso terapéutico , Coriorretinitis/tratamiento farmacológico , Tuberculosis Ocular/tratamiento farmacológico , Coriorretinitis/microbiología , Fondo de Ojo , Humanos , Síndrome Inflamatorio de Reconstitución Inmune/complicaciones , Masculino , Persona de Mediana Edad , Mycobacterium tuberculosis , Resultado del TratamientoRESUMEN
Healthy eyes and good vision are important determinants of populations' health across the globe. Sub-Saharan Africa is affected by simultaneous epidemics of ocular infections and human immunodeficiency virus (HIV). Ocular infection and its complications, along with cataract and ocular trauma, are common conditions in this region with great impact on daily life. In this review, we discuss the epidemiology, clinical manifestations and microbial aetiology of the most important infectious ocular conditions in sub-Saharan Africa: conjunctivitis, keratitis and uveitis. We focus specifically on the potential association of these infections with HIV infection, including immune recovery uveitis. Finally, challenges and opportunities for clinical management are discussed, and recommendations made to improve care in this neglected but very important clinical field.
Asunto(s)
Conjuntivitis/complicaciones , Epidemias , Infecciones del Ojo/complicaciones , Infecciones por VIH/complicaciones , Queratitis/complicaciones , Uveítis/complicaciones , África del Sur del Sahara/epidemiología , Infecciones del Ojo/epidemiología , HumanosRESUMEN
BACKGROUND: Vemurafenib, an inhibitor of genetically activated BRAF, is now commonly prescribed for metastatic melanoma harboring a BRAF mutation. Reports on side effects have focused on cutaneous complications. We here present a case of a severe pan-uveitis associated with vemurafenib use. CASE PRESENTATION: A 63-year old female was treated with the BRAF inhibitor vemurafenib for metastatic melanoma. After seven weeks of treatment, she developed near-complete visual loss in the course of a few days, as a result of severe uveitis. Vemurafenib had to be discontinued and systemic and topical corticosteroids were initiated. The visual symptoms improved slowly, however the cerebral metastases progressed and the patient died from her disease. CONCLUSION: Treatment with vemurafenib has become an important component of standard clinical care for patients with metastatic melanoma. In addition, it is one of the best examples of genotype-directed therapy. This case illustrates that vemurafenib-induced uveitis can develop fast and be slow to resolve. Awareness of this potentially severe side effect is of major importance to oncologists and aggressive treatment should be considered.
Asunto(s)
Antineoplásicos/efectos adversos , Neoplasias Encefálicas/tratamiento farmacológico , Indoles/efectos adversos , Melanoma/tratamiento farmacológico , Neoplasias Cutáneas/tratamiento farmacológico , Sulfonamidas/efectos adversos , Uveítis/diagnóstico , Antineoplásicos/uso terapéutico , Neoplasias Encefálicas/secundario , Resultado Fatal , Femenino , Humanos , Indoles/uso terapéutico , Melanoma/secundario , Persona de Mediana Edad , Neoplasias Cutáneas/patología , Sulfonamidas/uso terapéutico , Uveítis/inducido químicamente , VemurafenibAsunto(s)
Humor Acuoso/virología , Coriorretinitis/diagnóstico , Coriorretinitis/virología , Herpes Zóster Oftálmico/virología , Herpesvirus Humano 3/aislamiento & purificación , Aciclovir/análogos & derivados , Aciclovir/uso terapéutico , Adolescente , Antivirales/uso terapéutico , Coriorretinitis/tratamiento farmacológico , ADN Viral/análisis , Herpes Zóster Oftálmico/diagnóstico , Herpes Zóster Oftálmico/tratamiento farmacológico , Herpesvirus Humano 3/genética , Humanos , Masculino , Reacción en Cadena de la Polimerasa , Tomografía de Coherencia Óptica , Valaciclovir , Valina/análogos & derivados , Valina/uso terapéutico , Agudeza VisualRESUMEN
PURPOSE OF REVIEW: The aim of this article is to review the current literature concerning immune reconstitution inflammatory syndrome in relation to the eye. The definition, epidemiology, pathophysiology, risk factors, clinical features, diagnosis and treatment are discussed. RECENT FINDINGS: Immune reconstitution inflammatory syndrome affecting the eye has been documented in association with cytomegalovirus retinitis following the introduction of highly active antiretroviral therapy in a large number of patients. This syndrome is referred to as immune recovery uveitis, which is presumed to be mediated by recovery of immune responses specific to residual cytomegalovirus antigen located in the eye. In addition to improved immunity itself, risk factors include a low CD4 T count at the time of initiation of highly active antiretroviral therapy and involvement of a larger proportion of retina. Immune recovery uveitis is a major cause of visual loss and morbidity among patients with AIDS who are receiving highly active antiretroviral therapy. SUMMARY: Immune recovery uveitis is the most common form of immune reconstitution inflammatory syndrome in HIV-infected patients with cytomegalovirus retinitis who are receiving highly active antiretroviral therapy. Clear clinical definitions are required for ocular immune reconstitution inflammatory syndromes to avoid misclassification of other inflammatory conditions. A multidisciplinary approach is important in the diagnosis and management of immune recovery uveitis.